Excessive YAP signaling has been associated with liver steatosis and fibrosis in some preclinical models (53, 54), but in a carbon tetrachloride injury model, YAP activation through MST1/2 inhibition decreased fibrosis (23). The gene discussed is MST1; the disease is fatty liver disease.